ARTHROCARE CORP Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2013 12 months to Dec 31, 2013	FY2012 12 months to Dec 31, 2012	FY2011 12 months to Dec 31, 2011
Revenues:
Product sales
Royalties, fees and other
Total revenues
Cost of product sales
Gross profit
Operating expenses:
Research and development
Sales and marketing
General and administrative
Amortization of intangible assets
Exit costs
Investigation and restatement-related costs
Total operating expenses
Income (loss) from operations
Other income, net
Interest expense and bank fees
Foreign exchange loss, net
Total other expense
Income (loss) from continuing operations before income taxes
Income tax provision (benefit)
Net income (loss) from continuing operations
Income from discontinued operations, net of taxes
Net income (loss)
Accrued dividend and accretion charges on Series A 3% Redeemable Convertible Preferred Stock
Net income (loss) attributable to common stockholders
Other comprehensive income
Foreign currency adjustments
Total comprehensive income (loss)
Weighted-average shares outstanding:
Basic (in shares)
Diluted (in shares)
Earnings (loss) per share from continuing operations attributable to common stockholders:
Basic (in dollars per share)
Diluted (in dollars per share)
Earnings (loss) per share attributable to common stockholders:
Basic (in dollars per share)
Diluted (in dollars per share)

Comments